PL2831590T3 - Nowe markery molekularne raka płuca - Google Patents

Nowe markery molekularne raka płuca

Info

Publication number
PL2831590T3
PL2831590T3 PL13711661T PL13711661T PL2831590T3 PL 2831590 T3 PL2831590 T3 PL 2831590T3 PL 13711661 T PL13711661 T PL 13711661T PL 13711661 T PL13711661 T PL 13711661T PL 2831590 T3 PL2831590 T3 PL 2831590T3
Authority
PL
Poland
Prior art keywords
lung cancer
molecular markers
new molecular
new
markers
Prior art date
Application number
PL13711661T
Other languages
English (en)
Inventor
Daniel AJONA MARTÍNEZ-POLO
Leticia CORRALES PECINO
Luis MONTUENGA BADÍA
María José PAJARES VILLANDIEGO
Rubén PÍO OSÉS
Original Assignee
Proyecto De Biomedicina Cima, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proyecto De Biomedicina Cima, S.L. filed Critical Proyecto De Biomedicina Cima, S.L.
Publication of PL2831590T3 publication Critical patent/PL2831590T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4716Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL13711661T 2012-03-29 2013-03-20 Nowe markery molekularne raka płuca PL2831590T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12382113 2012-03-29
EP13711661.2A EP2831590B1 (en) 2012-03-29 2013-03-20 New lung cancer molecular markers
PCT/EP2013/055823 WO2013143940A1 (en) 2012-03-29 2013-03-20 New lung cancer molecular markers

Publications (1)

Publication Number Publication Date
PL2831590T3 true PL2831590T3 (pl) 2018-08-31

Family

ID=47988962

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13711661T PL2831590T3 (pl) 2012-03-29 2013-03-20 Nowe markery molekularne raka płuca

Country Status (9)

Country Link
US (1) US10545150B2 (pl)
EP (1) EP2831590B1 (pl)
DK (1) DK2831590T3 (pl)
ES (1) ES2670661T3 (pl)
HU (1) HUE036806T2 (pl)
NO (1) NO2831590T3 (pl)
PL (1) PL2831590T3 (pl)
PT (1) PT2831590T (pl)
WO (1) WO2013143940A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3361256A1 (en) * 2017-02-08 2018-08-15 Fundación para la Investigación Médica Aplicada In vitro method for the diagnosis of lung cancer
US20240229154A9 (en) * 2021-02-12 2024-07-11 Institut National de la Santé et de la Recherche Médicale Method for prognosis and treating a patient suffering from cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2342291T3 (es) * 2003-06-13 2010-07-05 University Of Pittsburgh Control de enfermedades inmunologicas, hematologicas e inflamatorias.
KR100899848B1 (ko) * 2008-07-21 2009-05-27 경북대학교 산학협력단 폐암 진단용 마커
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
EP2401406A4 (en) * 2009-02-25 2012-09-19 Cepheid METHODS OF DETECTING LUNG CANCER
KR100925147B1 (ko) * 2009-04-27 2009-11-05 경북대학교 산학협력단 폐암 진단용 마커

Also Published As

Publication number Publication date
US10545150B2 (en) 2020-01-28
NO2831590T3 (pl) 2018-08-11
ES2670661T3 (es) 2018-05-31
WO2013143940A1 (en) 2013-10-03
EP2831590B1 (en) 2018-03-14
HUE036806T2 (hu) 2018-08-28
US20150072361A1 (en) 2015-03-12
DK2831590T3 (en) 2018-05-22
PT2831590T (pt) 2018-05-10
EP2831590A1 (en) 2015-02-04

Similar Documents

Publication Publication Date Title
FR23C1020I2 (fr) Conjugues pyrrolobenzodiazepine-anticorps
IL289300A (en) Combination therapy for treating cancer
IL239147B (en) Molecular profiling for cancer
IL229319A0 (en) Biomarkers for lung cancer
BR112015004233A2 (pt) inalador.
IL252163A0 (en) Lung cancer biomarkers and uses thereof
DK2939692T3 (da) Nasal influenzavaccinesammensætning
DK2906251T3 (da) Pyrrolobenzodiazepin-anti-CD22-antistofkonjugater
BR112015008232A2 (pt) conjugados pirrolbenzodiazepina-anticorpo
BR112014029111A2 (pt) inalador
EP3954300C0 (en) ENDOBRONCHIAL CATHETER
EP2921192A4 (en) CATHETER
BR112015004230A2 (pt) inalador.
EP2912485A4 (en) POSITIONING
EP3332825C0 (en) NEBULIZER DEVICE
HUE045314T2 (hu) Kombinációs terápia rák kezelésére
EP2878300A4 (en) PLASTER
EP2934454C0 (en) Anti-dandruff composition
IL239447A0 (en) Novel compounds
EP2926857A4 (en) Catheter
BR112015009849A2 (pt) vanilina sintase
EP2820569A4 (en) MEDIA MARK
EP2851688A4 (en) MARKER FOR THE DETECTION OF PANCREATIC CANCER
HUE043162T2 (hu) Eljárás rák detektálására
EP2859892C0 (en) PAVEMENT